Grifols SA (Spain) Today
| GRF Stock | EUR 10.60 0.20 1.92% |
Performance6 of 100
| Odds Of DistressLess than 9
|
Grifols SA is trading at 10.60 as of the 24th of November 2024, a 1.92% up since the beginning of the trading day. The stock's open price was 10.4. Grifols SA has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. Equity ratings for Grifols SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of December 2022 and ending today, the 24th of November 2024. Click here to learn more.
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products primarily hemoderivatives. The company was founded in 1940 and is headquartered in Barcelona, Spain. GRIFOLS S operates under Drug ManufacturersGeneral classification in Spain and is traded on Madrid SE C.A.T.S.. The company has 422.18 M outstanding shares. More on Grifols SA
Moving against Grifols Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Grifols Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Grifols SA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Grifols SA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
Grifols SA (GRF) is traded on Madrid Exchange in Spain and employs 27,584 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.06 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Grifols SA's market, we take the total number of its shares issued and multiply it by Grifols SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Grifols SA operates under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 422.18 M outstanding shares.
Grifols SA has accumulated about 387.06 M in cash with 596.98 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.57.
Check Grifols SA Probability Of Bankruptcy
Ownership AllocationGrifols SA has a total of 422.18 Million outstanding shares. Grifols SA secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Grifols Ownership Details
Grifols SA Risk Profiles
Although Grifols SA's alpha and beta are two of the key measurements used to evaluate Grifols SA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.63 | |||
| Semi Deviation | 1.8 | |||
| Standard Deviation | 2.08 | |||
| Variance | 4.32 |
Grifols Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Grifols SA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
Grifols SA Corporate Management
Elected by the shareholders, the Grifols SA's board of directors comprises two types of representatives: Grifols SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Grifols. The board's role is to monitor Grifols SA's management team and ensure that shareholders' interests are well served. Grifols SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Grifols SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nuria Lapea | Risk Treasury | Profile | |
| M Tubau | Co Affairs | Profile | |
| Maria Llano | Chief Officer | Profile | |
| Steven JD | Ex Chairman | Profile | |
| Mateo Humbert | Co Officer | Profile | |
| Montserrat Llamas | Chief Officer | Profile | |
| Vctor Deu | CoCEO Director | Profile |
Other Information on Investing in Grifols Stock
Grifols SA financial ratios help investors to determine whether Grifols Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Grifols with respect to the benefits of owning Grifols SA security.